3B BlackBio Non-Covid sales for last 4 year (From kilpest annual report).
74% Growth in FY22, 66% growth in FY23.
Export revenue (Including Covid)
“Real business” numbers for this company are quite impressive. How well they can scale and to what level of revenue is a big question yet to be answered. But growth trajectory is outstanding.
| Subscribe To Our Free Newsletter |
